Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.430
-0.060 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
3.480
+0.050 (1.46%)
Pre-market: Apr 29, 2026, 8:32 AM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $374.29 million as of April 29, 2026. Its market cap has decreased by -33.39% in one year.
Market Cap
374.29M
Enterprise Value
210.24M
1-Year Change
-33.39%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $374.29M, an increase of 292.75%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 372.40M | -1.97% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 386.09M |
| Avalo Therapeutics | 385.22M |
| Enanta Pharmaceuticals | 384.65M |
| YD Bio | 383.95M |
| X4 Pharmaceuticals | 382.77M |
| Puma Biotechnology | 382.08M |
| Autolus Therapeutics | 377.92M |
| Immuneering | 372.66M |